CryoLife, Inc. · Kennesaw, GA United States (NYSE: CRY)
Key CryoLife, Inc. Financials
| Company Type | Public -(NYSE: CRY) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $116.6 |
| 2010 Employees | 393 |
CryoLife, Inc. Stock Quote (NYSE: CRY)
| Latest 02/15/12 11:12:15 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $5.58 | $5.62 | $5.58 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
CryoLife, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 116.6 | 111.7 | 105.1 |
| Cost of Goods Sold | 48.3 | 41.9 | 37.3 |
| Gross Profit | 68.4 | 69.8 | 67.8 |
| Gross Profit Margin | 58.6% | 62.5% | 64.5% |
| SG&A Expense | 49.1 | 50.0 | 48.8 |
| Depreciation & Amortization | 3.9 | 4.3 | 4.4 |
| Operating Income | 9.9 | 14.5 | 13.7 |
| Operating Margin | 8.5% | 13% | 13% |
| Nonoperating Income | (2.4) | (0.1) | (0.2) |
| Nonoperating Expenses | (0.2) | (0.0) | 0.1 |
| Income Before Taxes | 7.3 | 14.4 | 13.5 |
| Income Taxes | 3.3 | 5.7 | (19.4) |
| Net Income After Taxes | 3.9 | 8.7 | 32.9 |
| Continuing Operations | 3.9 | 8.7 | 32.9 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 3.9 | 8.7 | 32.9 |
| Total Net Income | 3.9 | 8.7 | 32.9 |
| Net Profit Margin | 3.4% | 7.8% | 31.3% |
| Diluted EPS from Total Net Income | 0.14 | 0.31 | 1.16 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
CryoLife, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 35.5 | 30.1 | 17.2 |
| Net Receivables | 14.3 | 14.6 | 14.0 |
| Inventories | 6.4 | 6.4 | 7.1 |
| Other Current Assets | 45.3 | 44.3 | 42.1 |
| Total Current Assets | 101.5 | 95.5 | 80.4 |
| Net Fixed Assets | 13.1 | 14.3 | 16.4 |
| Other Noncurrent Assets | 22.9 | 24.0 | 29.2 |
| Total Assets | 137.4 | 133.9 | 126.0 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 4.2 | 3.0 | 3.3 |
| Short-Term Debt | -- | -- | 0.0 |
| Other Current Liabilities | 15.1 | 16.3 | 17.7 |
| Total Current Liabilities | 19.3 | 19.2 | 21.0 |
| Long-Term Debt | 0.0 | 0.3 | 0.3 |
| Other Noncurrent Liabilities | 4.2 | 3.9 | 5.4 |
| Total Liabilities | 23.5 | 23.4 | 26.7 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | 0.0 | 0.0 |
| Common Stock Equity | 113.9 | 110.4 | 99.3 |
| Total Equity | 113.9 | 110.4 | 99.3 |
| Shares Outstanding (thou.) | 27,901.0 | 28,475.0 | 28,134.6 |
All amounts in millions of US Dollars except per share amounts.
CryoLife, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 21 | 17 | 10 |
| Net Investing Cash Flow | (10.7) | (4.4) | (4.3) |
| Net Financing Cash Flow | (4.7) | 0.7 | (2.4) |
| Net Change in Cash | 5.4 | 12.9 | 2.8 |
| Depreciation & Amortization | 3.9 | 4.3 | 4.4 |
| Capital Expenditures | (7.5) | (1.7) | (1.7) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.


